Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2005, Vol. 105, No. 6, pp. 2350-2355.
Prepublished online as a Blood First Edition Paper on November 2, 2004; DOI 10.1182/blood-2004-05-1963.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-05-1963v1
105/6/2350    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow Articles by Davis III, A. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D.
Right arrow Articles by Davis III, A. E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 25, 2004
Accepted October 25, 2004

C1 inhibitor prevents gram negative bacterial lipopolysaccharide-induced vascular permeability

Dongxu Liu, Dong Zhang, Jennifer Scafidi, Xiao Wu, Cort C Cramer, and Alvin E Davis III*

CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA, USA
Children's Hospital, Boston, MA, USA

* Corresponding author; email: aldavis{at}cbr.med.harvard.edu.

Gram negative bacterial endotoxemia may lead to the pathological increase of vascular permeability with systemic vascular collapse, a vascular leak syndrome, multiple organ failure (MOF), and/or shock. Previous studies demonstrated that C1 inhibitor (C1INH) protects mice from LPS-induced lethal septic shock via a direct interaction with lipopolysaccharide (LPS). Here, we report that C1INH blocked the LPS-induced increase in transendothelial flux through an endothelial monolayer. In addition, LPS-mediated detachment of cultured endothelial cells was prevented with C1INH. C1INH also inhibited LPS-induced endothelial cell apoptosis as demonstrated by suppression of DNA fragmentation and annexin V expression. As illustrated by laser scanning confocal microscopy, C1INH completely blocked the binding of FITC-LPS to human umbilical vein endothelial cells (HUVEC). C1INH protected from localized LPS-induced increased plasma leakage in C57BL/6J mice and in C1INH deficient mice. Local vascular permeability in response to LPS was increased to a greater extent in C1INH deficient mice in comparison with wild type littermate controls and was reversed by treatment with C1INH. Systemic administration of LPS to mice resulted in increased vascular permeability, which was reduced by C1INH. Therefore, these studies demonstrate that C1INH, in addition to its role in suppression of LPS-mediated macrophage activation, may play an important role in the prevention of LPS-mediated increased vascular permeability, endothelial cell injury, and multiple organ failure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020